nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ADRA1D—polycystic ovary syndrome	0.367	0.412	CbGaD
Terazosin—ADRA1B—polycystic ovary syndrome	0.313	0.352	CbGaD
Terazosin—ADRA1A—polycystic ovary syndrome	0.211	0.237	CbGaD
Terazosin—Alfuzosin—ADRA1D—polycystic ovary syndrome	0.00152	0.177	CrCbGaD
Terazosin—Alfuzosin—ADRA1B—polycystic ovary syndrome	0.0013	0.151	CrCbGaD
Terazosin—Doxazosin—ADRA1D—polycystic ovary syndrome	0.000991	0.115	CrCbGaD
Terazosin—Prazosin—ADRA1D—polycystic ovary syndrome	0.000913	0.106	CrCbGaD
Terazosin—Alfuzosin—ADRA1A—polycystic ovary syndrome	0.000875	0.102	CrCbGaD
Terazosin—Doxazosin—ADRA1B—polycystic ovary syndrome	0.000846	0.0984	CrCbGaD
Terazosin—Prazosin—ADRA1B—polycystic ovary syndrome	0.000779	0.0907	CrCbGaD
Terazosin—Nasal congestion—Metformin—polycystic ovary syndrome	0.000776	0.0434	CcSEcCtD
Terazosin—Pain in extremity—Metformin—polycystic ovary syndrome	0.000707	0.0396	CcSEcCtD
Terazosin—Migraine—Metformin—polycystic ovary syndrome	0.000696	0.0389	CcSEcCtD
Terazosin—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000632	0.0354	CcSEcCtD
Terazosin—Influenza—Metformin—polycystic ovary syndrome	0.000611	0.0342	CcSEcCtD
Terazosin—Angina pectoris—Metformin—polycystic ovary syndrome	0.000595	0.0333	CcSEcCtD
Terazosin—Doxazosin—ADRA1A—polycystic ovary syndrome	0.000569	0.0663	CrCbGaD
Terazosin—Prazosin—ADRA1A—polycystic ovary syndrome	0.000524	0.061	CrCbGaD
Terazosin—Rhinitis—Metformin—polycystic ovary syndrome	0.00049	0.0274	CcSEcCtD
Terazosin—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000482	0.027	CcSEcCtD
Terazosin—Eye disorder—Metformin—polycystic ovary syndrome	0.000457	0.0256	CcSEcCtD
Terazosin—Malnutrition—Metformin—polycystic ovary syndrome	0.000426	0.0238	CcSEcCtD
Terazosin—Flatulence—Metformin—polycystic ovary syndrome	0.000419	0.0235	CcSEcCtD
Terazosin—Dysgeusia—Metformin—polycystic ovary syndrome	0.000417	0.0233	CcSEcCtD
Terazosin—Vision blurred—Metformin—polycystic ovary syndrome	0.000401	0.0225	CcSEcCtD
Terazosin—Tremor—Metformin—polycystic ovary syndrome	0.000399	0.0223	CcSEcCtD
Terazosin—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000395	0.0221	CcSEcCtD
Terazosin—Malaise—Metformin—polycystic ovary syndrome	0.000384	0.0215	CcSEcCtD
Terazosin—Syncope—Metformin—polycystic ovary syndrome	0.000382	0.0214	CcSEcCtD
Terazosin—Palpitations—Metformin—polycystic ovary syndrome	0.000376	0.0211	CcSEcCtD
Terazosin—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000374	0.0209	CcSEcCtD
Terazosin—Chest pain—Metformin—polycystic ovary syndrome	0.000362	0.0203	CcSEcCtD
Terazosin—Myalgia—Metformin—polycystic ovary syndrome	0.000362	0.0203	CcSEcCtD
Terazosin—Discomfort—Metformin—polycystic ovary syndrome	0.000358	0.02	CcSEcCtD
Terazosin—Oedema—Metformin—polycystic ovary syndrome	0.000347	0.0194	CcSEcCtD
Terazosin—Shock—Metformin—polycystic ovary syndrome	0.000342	0.0191	CcSEcCtD
Terazosin—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00034	0.019	CcSEcCtD
Terazosin—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000336	0.0188	CcSEcCtD
Terazosin—Anorexia—Metformin—polycystic ovary syndrome	0.000331	0.0185	CcSEcCtD
Terazosin—Hypotension—Metformin—polycystic ovary syndrome	0.000325	0.0182	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000316	0.0177	CcSEcCtD
Terazosin—Paraesthesia—Metformin—polycystic ovary syndrome	0.000312	0.0175	CcSEcCtD
Terazosin—Dyspnoea—Metformin—polycystic ovary syndrome	0.00031	0.0173	CcSEcCtD
Terazosin—Somnolence—Metformin—polycystic ovary syndrome	0.000309	0.0173	CcSEcCtD
Terazosin—Dyspepsia—Metformin—polycystic ovary syndrome	0.000306	0.0171	CcSEcCtD
Terazosin—Decreased appetite—Metformin—polycystic ovary syndrome	0.000302	0.0169	CcSEcCtD
Terazosin—Fatigue—Metformin—polycystic ovary syndrome	0.000299	0.0168	CcSEcCtD
Terazosin—Constipation—Metformin—polycystic ovary syndrome	0.000297	0.0166	CcSEcCtD
Terazosin—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000286	0.016	CcSEcCtD
Terazosin—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000284	0.0159	CcSEcCtD
Terazosin—Abdominal pain—Metformin—polycystic ovary syndrome	0.000275	0.0154	CcSEcCtD
Terazosin—Prazosin—CYP1A1—polycystic ovary syndrome	0.000267	0.0311	CrCbGaD
Terazosin—Asthenia—Metformin—polycystic ovary syndrome	0.000249	0.014	CcSEcCtD
Terazosin—Pruritus—Metformin—polycystic ovary syndrome	0.000246	0.0138	CcSEcCtD
Terazosin—Diarrhoea—Metformin—polycystic ovary syndrome	0.000238	0.0133	CcSEcCtD
Terazosin—Dizziness—Metformin—polycystic ovary syndrome	0.00023	0.0129	CcSEcCtD
Terazosin—Vomiting—Metformin—polycystic ovary syndrome	0.000221	0.0124	CcSEcCtD
Terazosin—Rash—Metformin—polycystic ovary syndrome	0.000219	0.0123	CcSEcCtD
Terazosin—Dermatitis—Metformin—polycystic ovary syndrome	0.000219	0.0123	CcSEcCtD
Terazosin—Headache—Metformin—polycystic ovary syndrome	0.000218	0.0122	CcSEcCtD
Terazosin—Nausea—Metformin—polycystic ovary syndrome	0.000206	0.0116	CcSEcCtD
Terazosin—ADRA1D—Signaling by GPCR—SCT—polycystic ovary syndrome	3.95e-05	0.000481	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	3.93e-05	0.000479	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	3.92e-05	0.000478	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTGER3—polycystic ovary syndrome	3.91e-05	0.000477	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LHCGR—polycystic ovary syndrome	3.91e-05	0.000477	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	3.9e-05	0.000475	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NPB—polycystic ovary syndrome	3.89e-05	0.000474	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	3.88e-05	0.000473	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—LHB—polycystic ovary syndrome	3.85e-05	0.000469	CbGpPWpGaD
Terazosin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	3.8e-05	0.000464	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	3.77e-05	0.000459	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	3.76e-05	0.000459	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—ADRB2—polycystic ovary syndrome	3.72e-05	0.000454	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.68e-05	0.000448	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	3.68e-05	0.000448	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.66e-05	0.000446	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—SCT—polycystic ovary syndrome	3.61e-05	0.00044	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—FSHR—polycystic ovary syndrome	3.57e-05	0.000435	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	3.57e-05	0.000435	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—ADRB3—polycystic ovary syndrome	3.54e-05	0.000431	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	3.51e-05	0.000429	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—LHB—polycystic ovary syndrome	3.5e-05	0.000426	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	3.46e-05	0.000422	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—GNAS—polycystic ovary syndrome	3.45e-05	0.000421	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NPB—polycystic ovary syndrome	3.45e-05	0.000421	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.45e-05	0.000421	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	3.44e-05	0.00042	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	3.42e-05	0.000417	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—GNRH1—polycystic ovary syndrome	3.42e-05	0.000417	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—INHBB—polycystic ovary syndrome	3.36e-05	0.00041	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	3.34e-05	0.000408	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	3.32e-05	0.000405	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	3.31e-05	0.000403	CbGpPWpGaD
Terazosin—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	3.29e-05	0.000402	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—SCT—polycystic ovary syndrome	3.28e-05	0.000399	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTGER3—polycystic ovary syndrome	3.24e-05	0.000396	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LHCGR—polycystic ovary syndrome	3.24e-05	0.000396	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	3.2e-05	0.000391	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	3.14e-05	0.000383	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.14e-05	0.000383	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	3.13e-05	0.000381	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	3.12e-05	0.000381	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—LHB—polycystic ovary syndrome	3.11e-05	0.000379	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	3.07e-05	0.000374	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.06e-05	0.000373	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	3.06e-05	0.000373	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.05e-05	0.000372	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	3.04e-05	0.00037	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	3.03e-05	0.00037	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	3.03e-05	0.00037	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.03e-05	0.00037	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	2.95e-05	0.000359	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—SCT—polycystic ovary syndrome	2.91e-05	0.000355	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	2.88e-05	0.000351	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	2.88e-05	0.000351	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FSHR—polycystic ovary syndrome	2.86e-05	0.000349	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	2.82e-05	0.000344	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—POMC—polycystic ovary syndrome	2.8e-05	0.000342	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—INHBB—polycystic ovary syndrome	2.79e-05	0.00034	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.78e-05	0.000339	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	2.78e-05	0.000339	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	2.71e-05	0.000331	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	2.7e-05	0.000329	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.69e-05	0.000328	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.62e-05	0.000319	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	2.62e-05	0.000319	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.61e-05	0.000318	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FST—polycystic ovary syndrome	2.55e-05	0.000311	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	2.55e-05	0.00031	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	2.54e-05	0.00031	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.54e-05	0.000309	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.52e-05	0.000307	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LHB—polycystic ovary syndrome	2.49e-05	0.000303	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	2.49e-05	0.000303	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—INHBB—polycystic ovary syndrome	2.48e-05	0.000302	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.43e-05	0.000297	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	2.4e-05	0.000293	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	2.4e-05	0.000293	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FSHR—polycystic ovary syndrome	2.37e-05	0.000289	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.36e-05	0.000287	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.35e-05	0.000287	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SCT—polycystic ovary syndrome	2.33e-05	0.000284	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—POMC—polycystic ovary syndrome	2.32e-05	0.000283	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.32e-05	0.000282	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.31e-05	0.000281	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.3e-05	0.000281	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	2.26e-05	0.000275	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.23e-05	0.000272	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.22e-05	0.000271	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—FGF18—polycystic ovary syndrome	2.19e-05	0.000267	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	2.17e-05	0.000265	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.17e-05	0.000265	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—RBP4—polycystic ovary syndrome	2.17e-05	0.000264	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.16e-05	0.000263	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.14e-05	0.000261	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.13e-05	0.00026	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FST—polycystic ovary syndrome	2.12e-05	0.000258	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	2.11e-05	0.000257	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.1e-05	0.000257	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.09e-05	0.000255	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LHB—polycystic ovary syndrome	2.07e-05	0.000252	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	2.06e-05	0.000252	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.05e-05	0.00025	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—YAP1—polycystic ovary syndrome	2.02e-05	0.000247	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.02e-05	0.000246	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	2.01e-05	0.000245	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GAB1—polycystic ovary syndrome	2e-05	0.000243	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.99e-05	0.000242	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	1.98e-05	0.000242	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.96e-05	0.000238	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.95e-05	0.000238	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SCT—polycystic ovary syndrome	1.94e-05	0.000236	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.91e-05	0.000233	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—INSR—polycystic ovary syndrome	1.91e-05	0.000233	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	1.91e-05	0.000232	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	1.88e-05	0.000229	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	1.87e-05	0.000228	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	1.86e-05	0.000226	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.85e-05	0.000225	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	1.83e-05	0.000224	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—STAR—polycystic ovary syndrome	1.82e-05	0.000222	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.82e-05	0.000222	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—FGF18—polycystic ovary syndrome	1.81e-05	0.000221	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.81e-05	0.000221	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—RBP4—polycystic ovary syndrome	1.8e-05	0.000219	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	1.79e-05	0.000219	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.79e-05	0.000218	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.79e-05	0.000218	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.77e-05	0.000216	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PGR—polycystic ovary syndrome	1.77e-05	0.000215	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.74e-05	0.000212	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.73e-05	0.000211	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	1.72e-05	0.00021	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.7e-05	0.000207	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—YAP1—polycystic ovary syndrome	1.68e-05	0.000205	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GAB1—polycystic ovary syndrome	1.66e-05	0.000202	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PLAT—polycystic ovary syndrome	1.64e-05	0.0002	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GHRL—polycystic ovary syndrome	1.64e-05	0.0002	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.64e-05	0.0002	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.62e-05	0.000198	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.62e-05	0.000198	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.61e-05	0.000197	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.6e-05	0.000195	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.59e-05	0.000194	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—INSR—polycystic ovary syndrome	1.58e-05	0.000193	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.58e-05	0.000193	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.57e-05	0.000192	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ATF1—polycystic ovary syndrome	1.57e-05	0.000191	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.55e-05	0.000188	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.53e-05	0.000186	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.53e-05	0.000186	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.52e-05	0.000186	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.51e-05	0.000184	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.49e-05	0.000182	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.48e-05	0.000181	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.47e-05	0.000179	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PGR—polycystic ovary syndrome	1.47e-05	0.000179	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NGFR—polycystic ovary syndrome	1.45e-05	0.000176	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—POMC—polycystic ovary syndrome	1.44e-05	0.000175	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PRL—polycystic ovary syndrome	1.43e-05	0.000175	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.41e-05	0.000172	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.41e-05	0.000172	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.38e-05	0.000168	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.38e-05	0.000168	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PLAT—polycystic ovary syndrome	1.36e-05	0.000166	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GHRL—polycystic ovary syndrome	1.36e-05	0.000166	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.36e-05	0.000166	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.34e-05	0.000163	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.33e-05	0.000163	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.32e-05	0.00016	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.31e-05	0.00016	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.3e-05	0.000159	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.3e-05	0.000159	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.27e-05	0.000155	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.26e-05	0.000154	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GNAS—polycystic ovary syndrome	1.26e-05	0.000154	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.23e-05	0.00015	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.21e-05	0.000148	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.21e-05	0.000148	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.2e-05	0.000146	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.2e-05	0.000146	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.19e-05	0.000145	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	1.19e-05	0.000145	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.19e-05	0.000145	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NRG1—polycystic ovary syndrome	1.18e-05	0.000144	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.17e-05	0.000142	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.16e-05	0.000141	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.15e-05	0.00014	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.15e-05	0.00014	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.13e-05	0.000138	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.13e-05	0.000137	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.12e-05	0.000137	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.1e-05	0.000134	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.09e-05	0.000133	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.07e-05	0.00013	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.06e-05	0.000129	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.06e-05	0.000129	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.05e-05	0.000128	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.03e-05	0.000125	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.02e-05	0.000124	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.01e-05	0.000123	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IRS2—polycystic ovary syndrome	1.01e-05	0.000123	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1e-05	0.000122	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.97e-06	0.000122	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LEP—polycystic ovary syndrome	9.88e-06	0.000121	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	9.79e-06	0.000119	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	9.3e-06	0.000113	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.86e-06	0.000108	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IRS1—polycystic ovary syndrome	8.82e-06	0.000108	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—TH—polycystic ovary syndrome	8.75e-06	0.000107	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	8.69e-06	0.000106	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	8.51e-06	0.000104	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—POMC—polycystic ovary syndrome	8.49e-06	0.000104	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—INS—polycystic ovary syndrome	8.44e-06	0.000103	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	8.38e-06	0.000102	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	8.2e-06	0.0001	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	8.17e-06	9.96e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	8.16e-06	9.95e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	8e-06	9.76e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.76e-06	9.46e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	7.45e-06	9.08e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	7.32e-06	8.92e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	7.29e-06	8.88e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	7.14e-06	8.71e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	7.05e-06	8.59e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	7.01e-06	8.55e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	6.81e-06	8.3e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	6.78e-06	8.27e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	6.77e-06	8.26e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	6.5e-06	7.93e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	6.45e-06	7.87e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.44e-06	7.85e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	6.26e-06	7.63e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	6.25e-06	7.62e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	6.22e-06	7.59e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.02e-06	7.34e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.02e-06	7.34e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	6.01e-06	7.33e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.72e-06	6.97e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.33e-06	6.5e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	5.18e-06	6.32e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.88e-06	5.95e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.81e-06	5.86e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.78e-06	5.83e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.6e-06	5.61e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.43e-06	5.4e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.93e-06	4.8e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	3.69e-06	4.5e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	3.06e-06	3.73e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	2.72e-06	3.32e-05	CbGpPWpGaD
